订阅小程序
旧版功能

CCL18 is an IL-6 Responsive Biomarker in Systemic Sclerosis Associated Interstitial Lung Disease-Analysis from Phase 3 Trial of Tocilizumab

T. Ramalingam,M. Neighbors, C. Schiffman, X. Gao,X. R. Sheng, J. Jiang,C. J. F. Lin,D. Khanna

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE（2020）

引用 0|浏览52
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要